Before the Vaccines: Medical Treatments of Acute Paralysis in the 1916 New York Epidemic of Poliomyelitis

H.V, Wyatt

doi:10.2174/1874285801408010144

Cited by 4 publications

(1 citation statement)

References 6 publications

(7 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A literature study reported that serotherapy was used during the Spanish flu (influenza A) pandemic in 1918-1920 for the first time, but this therapy was also used before the Spanish flu pandemic [3]. Serotherapy was tried as a therapeutic treatment in a poliomyelitis outbreak in New York in 1916 [28]. In 1916 (Tunis), some researchers again performed this therapy for the measles [6].…”

Section: History Of Convalescent Plasmamentioning

confidence: 99%

Convalescent Plasma: An Evidence-Based Old Therapy to Treat Novel Coronavirus Patients

Shubham¹,

Devi²,

Sarkar³

et al. 2022

Biotechnology to Combat COVID-19

View full text Add to dashboard Cite

Novel Coronavirus (nCoV-2019) is a highly infectious viral outbreak that has so far infected more than 110 million people worldwide. Fast viral transmission and high infection rates have severely affected the entire population, especially the old aged and comorbid individuals leaving significantly less time to find some effective treatment strategy. In these challenging times, convalescent plasma (CP) therapy came as a ray of hope to save humankind. It is a form of passive immunization that has been used to treat various infectious diseases since 1890, including the 1918 Spanish flu, 2002/03 SARS-CoV, 2009 H1N1, 2012 MERS-CoV, and 2014 Ebola outbreak. The transfusion includes administration of CP containing a high value of neutralizing antibodies against the virus in hospitalized patients. This chapter summarizes the potential outcome of CP therapy in the treatment of nCoV-2019 patients.

show abstract

Section: History Of Convalescent Plasmamentioning

confidence: 99%